191 related articles for article (PubMed ID: 34715942)
1. A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes.
Tauziède-Espariat A; Pierron G; Guillemot D; Sievers P; Cazals-Hatem D; Faillot T; Roux A; Benzakoun J; Bockel S; Weinbreck N; Hasty L; Lechapt E; Chrétien F; Varlet P
Acta Neuropathol Commun; 2021 Oct; 9(1):174. PubMed ID: 34715942
[TBL] [Abstract][Full Text] [Related]
2. A novel SMARCA2-CREM fusion expending the molecular spectrum of salivary gland hyalinazing clear cell carcinoma beyond the FET genes.
Lanic MD; Guérin R; Sater V; Durdilly P; Ruminy P; Skálová A; Laé M
Genes Chromosomes Cancer; 2023 Apr; 62(4):231-236. PubMed ID: 36504225
[TBL] [Abstract][Full Text] [Related]
3. Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas.
Sloan EA; Gupta R; Koelsche C; Chiang J; Villanueva-Meyer JE; Alexandrescu S; Eschbacher JM; Wang W; Mafra M; Ud Din N; Carr-Boyd E; Watson M; Punsoni M; Oviedo A; Gilani A; Kleinschmidt-DeMasters BK; Coss DJ; Lopes MB; Reddy A; Mueller S; Cho SJ; Horvai AE; Lee JC; Pekmezci M; Tihan T; Bollen AW; Rodriguez FJ; Ellison DW; Perry A; von Deimling A; Chang SM; Berger MS; Solomon DA
Brain Pathol; 2022 Jul; 32(4):e13037. PubMed ID: 34821426
[TBL] [Abstract][Full Text] [Related]
4. An extracranial CNS presentation of the emerging "intracranial" mesenchymal tumor, FET: CREB-fusion positive.
Tauziède-Espariat A; Pierron G; Guillemot D; Benevello C; Pallud J; Benzakoun J; Hasty L; Métais A; Chrétien F; Varlet P
Brain Tumor Pathol; 2023 Jan; 40(1):35-39. PubMed ID: 36107277
[TBL] [Abstract][Full Text] [Related]
5. Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms.
Sloan EA; Chiang J; Villanueva-Meyer JE; Alexandrescu S; Eschbacher JM; Wang W; Mafra M; Ud Din N; Carr-Boyd E; Watson M; Punsoni M; Oviedo A; Gilani A; Kleinschmidt-DeMasters BK; Coss DJ; Lopes MB; Raffel C; Berger MS; Chang SM; Reddy A; Ramani B; Ferris SP; Lee JC; Hofmann JW; Cho SJ; Horvai AE; Pekmezci M; Tihan T; Bollen AW; Rodriguez FJ; Ellison DW; Perry A; Solomon DA
Brain Pathol; 2021 Jul; 31(4):e12918. PubMed ID: 33141488
[TBL] [Abstract][Full Text] [Related]
6. Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor.
Mezzacappa FM; Smith FK; Zhang W; Gard A; Cabuk FK; Gonzalez-Gomez I; Monforte HL; Liang J; Singh O; Quezado MM; Aldape KD; Gokden M; Bridge JA; Chen J
Acta Neuropathol Commun; 2024 Jan; 12(1):17. PubMed ID: 38291529
[TBL] [Abstract][Full Text] [Related]
7. ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review.
Gareton A; Pierron G; Mokhtari K; Tran S; Tauziède-Espariat A; Pallud J; Louvel G; Meary E; Capelle L; Chrétien F; Varlet P
J Neuropathol Exp Neurol; 2018 Jul; 77(7):537-541. PubMed ID: 29788195
[TBL] [Abstract][Full Text] [Related]
8. EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial Location.
Kao YC; Sung YS; Zhang L; Chen CL; Vaiyapuri S; Rosenblum MK; Antonescu CR
Am J Surg Pathol; 2017 Apr; 41(4):482-490. PubMed ID: 28009602
[TBL] [Abstract][Full Text] [Related]
9. A case of intracranial myxoid mesenchymal tumor with EWSR1:CREM fusion in an adult female: Extensive immunohistochemical evaluation.
Kambe A; Kuwamoto S; Shimizu T; Amisaki H; Sakamoto M; Inagaki H; Kurosaki M
Neuropathology; 2021 Aug; 41(4):315-323. PubMed ID: 34258808
[TBL] [Abstract][Full Text] [Related]
10. Intracranial myxoid angiomatoid fibrous histiocytoma with "classic" histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors.
Tan NJH; Pratiseyo PD; Wahjoepramono EJ; Kuick CH; Goh JY; Chang KTE; Tan CL
Neuropathology; 2021 Aug; 41(4):306-314. PubMed ID: 34254369
[TBL] [Abstract][Full Text] [Related]
11. An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.
Tauziède-Espariat A; Sievers P; Larousserie F; Benzakoun J; Guillemot D; Pierron G; Duchesne M; Uro-Coste E; Roux A; Vasiljevic A; Fenouil T; Meyronet D; Mokhtari K; Polivka M; Rousseau A; Bost-Bezeaud F; Akoury S; Pallud J; Benevello C; Hasty L; Gareton A; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Puget S; Sahm F; Varlet P;
Brain Pathol; 2022 Jan; 32(1):e13010. PubMed ID: 34314078
[TBL] [Abstract][Full Text] [Related]
12. Intracranial Myxoid Mesenchymal Tumor/Myxoid Subtype Angiomatous Fibrous Histiocytoma: Diagnostic and Prognostic Challenges.
Domingo RA; Vivas-Buitrago T; Jentoft M; Quinones-Hinojosa A
Neurosurgery; 2020 Dec; 88(1):E114-E122. PubMed ID: 32970137
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation caused by an intracranial mesenchymal tumor with a EWSR1::CREM fusion presenting associated with IL-6/STAT3 signaling.
Hojo K; Furuta T; Komaki S; Yoshikane Y; Kikuchi J; Nakamura H; Ide M; Shima S; Hiyoshi Y; Araki J; Tanaka S; Ozono S; Yoshida A; Nobusawa S; Morioka M; Nishikomori R
Neuropathology; 2023 Jun; 43(3):244-251. PubMed ID: 36328767
[TBL] [Abstract][Full Text] [Related]
14. Brain parenchymal angiomatoid fibrous histiocytoma and spinal myxoid mesenchymal tumor with FET: CREB fusion, a spectrum of the same tumor type.
Kim NR; Kim SI; Park JW; Park CK; Chung CK; Choi SH; Yun H; Park SH
Neuropathology; 2022 Aug; 42(4):257-268. PubMed ID: 35730186
[TBL] [Abstract][Full Text] [Related]
15. Intracranial myxoid mesenchymal tumors with EWSR1-CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity?
Bale TA; Oviedo A; Kozakewich H; Giannini C; Davineni PK; Ligon K; Alexandrescu S
Brain Pathol; 2018 Mar; 28(2):183-191. PubMed ID: 28281318
[TBL] [Abstract][Full Text] [Related]
16. Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion.
Yoshida A; Wakai S; Ryo E; Miyata K; Miyazawa M; Yoshida KI; Motoi T; Ogawa C; Iwata S; Kobayashi E; Watanabe SI; Kawai A; Mori T
Am J Surg Pathol; 2019 Dec; 43(12):1622-1630. PubMed ID: 31305268
[TBL] [Abstract][Full Text] [Related]
17. EWSR1-CREM fusion in pulmonary mesenchymal neoplasm showing distinctive clear cell morphology.
Komatsu M; Sakai Y; Nishikubo M; Tane S; Nishio W; Kajimoto K; Hirose T
Pathol Int; 2020 Dec; 70(12):1020-1026. PubMed ID: 33002291
[TBL] [Abstract][Full Text] [Related]
18. Expanding the Spectrum of
Koh S; Punjabi LS; Chang KTE; Wei Yang Teo N; Ee Hoon Teo C; Soh SY; Kun Kiaang Tan H
Pediatr Dev Pathol; 2024; 27(1):90-95. PubMed ID: 37818644
[No Abstract] [Full Text] [Related]
19. A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions.
Tauziède-Espariat A; Chotard G; le Loarer F; Baud J; Azmani R; Dangouloff-Ros V; Boddaert N; Icher-de-Bouyn C; Gimbert E; Hasty L; Métais A; Chrétien F; Varlet P;
Acta Neuropathol Commun; 2022 Feb; 10(1):15. PubMed ID: 35115049
[TBL] [Abstract][Full Text] [Related]
20. Intracranial Myxoid Mesenchymal Tumor with Rare EWSR1-CREM Translocation.
White MD; McDowell MM; Pearce TM; Bukowinski AJ; Greene S
Pediatr Neurosurg; 2019; 54(5):347-353. PubMed ID: 31430747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
